May 28, 2023

Volume XIII, Number 148

Advertisement
Advertisement

May 26, 2023

Subscribe to Latest Legal News and Analysis

May 25, 2023

Subscribe to Latest Legal News and Analysis

Biotechnology, Life Sciences, Food and Drug Law News

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Date Title Organization
26
May
ECHA Publishes Annual Report on Helpdesk Activities Bergeson & Campbell, P.C.
26
May
China Proposes to Amend GB 4806.1 General Safety Standard for Food-Contact Materials Keller and Heckman LLP
26
May
Analogous Art Must Be Compared to Challenged Patent McDermott Will & Emery
26
May
Mcdermottplus Check-Up: May 26, 2023 McDermott Will & Emery
25
May
Florida Bans Offshoring of Certain Patient Information Sheppard, Mullin, Richter & Hampton LLP
25
May
Supreme Court Unanimously Affirms Amgen Repatha® Antibody Patents Invalid for Lack of Enablement Mintz
25
May
Salmonella Outbreak Linked to Papa Murphy’s Cookie Dough Keller and Heckman LLP
25
May
Minnesota Legislature Passes New Recreational Marijuana Bill Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
25
May
EPA Will Propose Updates to New Chemicals Regulations to Improve Efficiency, Remove LVE and LoREX Exemptions for PFAS and Certain PBTs Bergeson & Campbell, P.C.
25
May
FDA Establishes Public Docket Soliciting Comments on Nitrosamine Drug Substance-Related Impurities Nelson Mullins
25
May
White House OSTP Extends Comment Period for RFI on NNI EHS Research Strategy Bergeson & Campbell, P.C.
24
May
Implementation of FASTER Act Poses Challenge for Industry Keller and Heckman LLP
24
May
Sequencing the Impact: How AI is Boosting Genomic Medicine Foley & Lardner LLP
24
May
Mississippi Department of Health Revises Medical Cannabis Regulations: Feels Like I’ve Been Here Before Bradley Arant Boult Cummings LLP
23
May
Registration Opens for NNI’s Second Webinar on U.S. Government Activities Addressing Micro- and Nanoplastic Issues Bergeson & Campbell, P.C.
23
May
Marijuana in the Manufacturing Workplace Jackson Lewis P.C.
23
May
More Federal Action in the Pharmaceutical Sector as PBM Bill Advances in the Senate Epstein Becker & Green, P.C.
22
May
Supreme Court Voids Amgen’s Patents using “Undue Experimentation” Standard Schwegman, Lundberg & Woessner, P.A.
19
May
Supreme Court Delivers the Final Blow to Amgen Bradley Arant Boult Cummings LLP
19
May
FDA Issues Draft Guidance on Decentralized Clinical Trials for Drugs, Biological Products and Devices McDermott Will & Emery

Pages

Advertisement
Advertisement
Advertisement